Ignite Creation Date:
2025-12-24 @ 3:53 PM
Ignite Modification Date:
2026-06-20 @ 5:24 AM
Study NCT ID:
NCT00666692
Status:
COMPLETED
Last Update Posted:
2012-04-27
First Post:
2008-04-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)
Sponsor:
Abbott
Organization: